Role of ghrelin in food reward: impact of ghrelin on sucrose self‐administration and mesolimbic dopamine and acetylcholine receptor gene expression

Abstract

The decision to eat is strongly influenced by non‐homeostatic factors such as food palatability. Indeed, the rewarding and motivational value of food can override homeostatic signals, leading to increased consumption and hence, obesity. Ghrelin, a gut‐derived orexigenic hormone, has a prominent role in homeostatic feeding. Recently, however, it has emerged as a potent modulator of the mesolimbic dopaminergic reward pathway, suggesting a role for ghrelin in food reward. Here, we sought to determine whether ghrelin and its receptors are important for reinforcing motivation for natural sugar reward by examining the role of ghrelin receptor (GHS‐R1A) stimulation and blockade for sucrose progressive ratio operant conditioning, a procedure used to measure motivational drive to obtain a reward. Peripherally and centrally administered ghrelin significantly increased operant responding and therefore, incentive motivation for sucrose. Utilizing the GHS‐R1A antagonist JMV2959, we demonstrated that blockade of GHS‐R1A signaling significantly decreased operant responding for sucrose. We further investigated ghrelin's effects on key mesolimbic reward nodes, the ventral tegmental area (VTA) and nucleus accumbens (NAcc), by evaluating the effects of chronic central ghrelin treatment on the expression of genes encoding major reward neurotransmitter receptors, namely dopamine and acetylcholine. Ghrelin treatment was associated with an increased dopamine receptor D5 and acetylcholine receptor nAChRβ2 gene expression in the VTA and decreased expression of D1, D3, D5 and nAChRα3 in the NAcc. Our data indicate that ghrelin plays an important role in motivation and reinforcement for sucrose and impacts on the expression of dopamine and acetylcholine encoding genes in the mesolimbic reward circuitry. These findings suggest that ghrelin antagonists have therapeutic potential for the treatment of obesity and to suppress the overconsumption of sweet food.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 68

1. 1.

   Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschop MH, Gao XB, Horvath TL. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116:3229-3239.

   Not in our library10.1172/jci29867

2. 2.

   Alsio J, Olszewski PK, Norback AH, Gunnarsson ZE, Levine AS, Pickering C, Schioth HB. Dopamine D1 receptor gene expression decreases in the nucleus accumbens upon long-term exposure to palatable food and differs depending on diet-induced obesity phenotype in rats. Neuroscience. 2010;171:779-787.

   Not in our library10.1016/j.neuroscience.2010.09.046

3. 3.

   Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected Ghrelin in the rat. J Neurosci. 2006;26:11052-11060.

   Not in our library10.1523/jneurosci.2606-06.2006

4. 4.

   Bailey ART, Von Englehardt N, Leng G, Smith RG, Dickson SL. Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway. J Neuroendocrinol. 2000;12:191-197.

   Not in our library10.1046/j.1365-2826.2000.00398.x

5. 5.

   Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood–brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822-827.

   Not in our library10.1124/jpet.102.034827

6. 6.

   Brown CM, Fletcher PJ, Coscina DV. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides. 1998;19:1667-1673.

   Not in our library10.1016/s0196-9781(98)00117-x

7. 7.

   Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, Levey AI. Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse. 2000;37:125-145.

   Not in our library10.1002/1098-2396(200008)37:2<125::aid-syn7>3.0.co;2-7

8. 8.

   Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu HY, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-661.

   Not in our library10.1016/s0896-6273(03)00063-1

9. 9.

   Cragg SJ, Greenfield SA. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci. 1997;17:5738-5746.

   Not in our library10.1523/jneurosci.17-15-05738.1997

10. 10.

    Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.

    Not in our library10.2337/diabetes.50.8.1714

11. 11.

    Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315:1267-1270.

    Not in our library10.1126/science.1137073

12. 12.

    Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120-1128.

    Not in our library10.1053/gast.2002.35954

13. 13.

    Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL. Ghrelin controls hippocampal spine synapse density and memory performance. Nature Neuroscience. 2006;9:381-388.

    Not in our library10.1038/nn1656

14. 14.

    Dickson SL, Hrabovszky E, Hansson C, Jerlhag E, Alvarez-Crespo M, Skibicka KP, Molnar CS, Liposits Z, Engel JA, Egecioglu E. Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience. 2010;171:1180-1186.

    Not in our library10.1016/j.neuroscience.2010.10.005

15. 15.

    Dickson SL, Leng G, Robinson ICAF. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience. 1993;53:303-306.

    Not in our library10.1016/0306-4522(93)90197-n

16. 16.

    Dickson SL, Luckman SM. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology. 1997;138:771-777.

    Not in our library10.1210/endo.138.2.4907

17. 17.

    Dornonville de la Cour CD, Björkqvist M, Sandvik AK, Bakke I, Zhao CM, Chen D, Håkanson R. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept. 2001;99:141-150.

    Not in our library10.1016/s0167-0115(01)00243-9

18. 18.

    Dornonville de la Cour CD, Lindqvist A, Egecioglu E, Tung YCL, Surve V, Ohlsson C, Jansson JO, Erlanson-Albertsson C, Dickson SL, Hakanson R. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut. 2005;54:907-913.

    Not in our library10.1136/gut.2004.058578

19. 19.
    PRECLINICAL STUDY: FULL ARTICLE: Ghrelin increases intake of rewarding food in rodents · 2010

    No notice
20. 20.

    Engel JA. Neurochemical aspects of the europhoria induced by dependence-producing drugs. Recent Advances in the Study of Alcoholism (Excerpta Medica International Congress Series). 1977;16-22.

    Not in our library

21. 21.

    Esler WP, Rudolph J, Claus TH, Tang WF, Barucci N, Brown SE, Bullock W, Daly M, DeCarr L, Li YX, Milardo L, Molstad D, Zhu J, Gardell SJ, Livingston JN, Sweet LJ. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology. 2007;148:5175-5185.

    Not in our library10.1210/en.2007-0239

22. 22.

    Faulconbridge LF, Cummings DE, Kaplan JM, Grill HJ. Hyperphagic effects of brainstem ghrelin administration. Diabetes. 2003;52:2260-2265.

    Not in our library10.2337/diabetes.52.9.2260

23. 23.

    Faulconbridge LF, Grill HJ, Kaplan JM, Daniels D. Caudal brainstem delivery of ghrelin induces fos expression in the-nucleus of the solitary tract, but not in the arcuate or paraventricular nuclei of the hypothalamus. Brain Res. 2008;1218:151-157.

    Not in our library10.1016/j.brainres.2008.04.068

24. 24.

    Figlewicz DP, Bennett JL, Naleid AM, Davis C, Grimm JW. Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiol Behav. 2006;89:611-616.

    Not in our library10.1016/j.physbeh.2006.07.023

25. 25.

    Gualillo O, Caminos JE, Nogueiras R, Seoane LM, Arvat E, Ghigo E, Casanueva FF, Dieguez C. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. Obes Res. 2002;10:682-687.

    Not in our library10.1038/oby.2002.92

26. 26.

    Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437:556-559.

    Not in our library10.1038/nature04071

27. 27.

    Helm KA, Rada P, Hoebel BG. Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism. Brain Res. 2003;963:290-297.

    Not in our library10.1016/s0006-8993(02)04051-9

28. 28.

    Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol. 2000;12:1047-1049.

    Not in our library10.1046/j.1365-2826.2000.00584.x

29. 29.

    Hodos W. Progressive ratio as a measure of reward strength. Science. 1961;134:943-944.

    Not in our library10.1126/science.134.3483.943

30. 30.

    Hoebel BG, Avena NM, Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol. 2007;7:617-627.

    Not in our library10.1016/j.coph.2007.10.014

31. 31.

    Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW. High constitutive signaling of the ghrelin receptor––identification of a potent inverse agonist. Mol Endocrinol. 2003;17:2201-2210.

    Not in our library10.1210/me.2003-0069

32. 32.

    Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, VanderPloeg LHT. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273:974-977.

    Not in our library10.1126/science.273.5277.974

33. 33.

    Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol. 2008;13:358-363.

    Not in our library10.1111/j.1369-1600.2008.00125.x

34. 34.

    Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol. 2006;11:45-54.

    Not in our library10.1111/j.1369-1600.2006.00002.x

35. 35.

    Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007;12:6-16.

    Not in our library10.1111/j.1369-1600.2006.00041.x

36. 36.

    Jerlhag E, Egecioglu E, Dickson SL, Svensson L, Engel JA. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur Neuropsychopharmacol. 2008;18:508-518.

    Not in our library10.1016/j.euroneuro.2008.02.006

37. 37.

    Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, Moechars D, Datta R, Perrissoud D, Dickson SL, Engel JA. Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A. 2009;106:11318-11323.

    Not in our library10.1073/pnas.0812809106

38. 38.

    Jewett DC, Cleary J, Levine AS, Schaal DW, Thompson T. Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior. Psychopharmacology. 1995;120:267-271.

    Not in our library10.1007/bf02311173

39. 39.

    Keen-Rhinehart E, Bartness TJ. MTII attenuates ghrelin- and food deprivation-induced increases in food hoarding and food intake. Horm Behav. 2007a;52:612-620.

    Not in our library10.1016/j.yhbeh.2007.07.014

40. 40.

    Keen-Rhinehart E, Bartness TJ. NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake. Am J Physiol Regul Integr Comp Physiol. 2007b;292:R1728-1737.

    Not in our library10.1152/ajpregu.00597.2006

Cited by papers we hold 4

• From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation · 2017
  No notice
• Ghrelin · 2015
  No notice
• Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward · 2013
  No notice
• The Amygdala as a Neurobiological Target for Ghrelin in Rats: Neuroanatomical, Electrophysiological and Behavioral Evidence · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.